Business
Beryl Drugs Limited Press Release Jun 08 2026
The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Sudhir Sethi
About this update from Beryl Drugs Limited
The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Sudhir Sethi View Attachment
View stock analysis, news, and events for Beryl Drugs Limited